Review article: Monitoring the activity of Crohn's disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 4, 2002, Pages 29-33

  Biancone, L ^a   De Nigris, F ^a   Del Vecchio Blanco, G ^a   Monteleone, I ^a   Vavassori, P ^a   Geremia, A ^a   Pallone, F ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; CALPROTECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CYTOKINE;

CELL ACTIVATION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE COURSE; DOWN REGULATION; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOCOMPETENT CELL; LAMINA PROPRIA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RELAPSE; REMISSION; REVIEW; HEALTH SURVEY; HOSPITALIZATION; IMMUNOLOGY; METABOLISM; PROGNOSIS; RECURRENT DISEASE;

BIOLOGICAL MARKERS; CROHN DISEASE; CYTOKINES; HEALTH STATUS INDICATORS; HUMAN; PROGNOSIS; RECURRENCE; SEVERITY OF ILLNESS INDEX; HUMANS;

EID: 0036268520     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Medical therapy for Crohn's disease
2. Current treatment modalities in active Crohn's Disease
3. Proposed classification of patient subgroups in Crohn's Disease. Working Team report
4. Conservative management of small intestinal obstruction in Crohn's disease
5. National Cooperative Crohn's disease Study (ECCDS): Results of drug treatment
6. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
7. Review article. The medical management of Crohn's disease
8. Management of Crohn's disease in adults
9. Prevalence and incidence of inflammatory bowel disease in family members
10. Stress and physical activity: Are they risk factors for inflammatory bowel disease?
11. Smoking and inflammatory bowel disease
12. Studies of family history among patients with inflammatory bowel disease
13. Crohn's disease: Concordance for site and clinical type in affected family members - Potential hereditary influences
14. Measuring the 'activity' of Crohn's disease
15. Development of a Crohn's disease activity index
16. Analysis of biological variables in Crohn's Disease
17. The clinical significance of serum C reactive protein levels in Crohn's Disease. Results of a prospective longitudinal study
18. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
19. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum
20. Fecal alpha-1-antitripsin as early indicator of clinical relapse in Crohn's disease: Results from a 4 year follow up
21. Molecular evidence for two forms of Crohn's disease
22. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's Disease
23. Frequently relapsing Crohn's disease is characterised by persistent elevation in Interleukin-6 and soluble interleukin-2 receptor serum levels during remission
24. 123I-Interleukin-2 scintigraphy for in vivo assessment of intestinal monovascular cell infestation in Crohn's disease
25. Mechanisms in failure of Infliximab for Crohn's Disease
26. TNF-α secretion as a predictor of clinical relapse in patients with steroid induced remission